Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 10:15 am Purchase | 2026-06-30 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Armistice Capital, LLC | 387,038 4.990% | 95,883 (+32.93%) | Filing History |
| 2026-08-13 12:56 pm Sale | 2026-06-30 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Ayrton Capital LLC | 118,715 1.590% | -4,691,736 (-97.53%) | Filing History |
| 2026-08-13 10:17 am Purchase | 2026-06-30 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Mitchell P. Kopin | 273,657 4.990% | 40,320 (+17.28%) | Filing History |
| 2026-08-10 4:39 pm Purchase | 2026-06-30 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | JANE STREET GROUP LLC | 315,275 4.300% | 22,442 (+7.66%) | Filing History |
| 2026-06-09 7:09 pm Purchase | 2026-06-03 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | JANE STREET GROUP LLC | 292,833 5.600% | 292,833 (New Position) | Filing History |
| 2026-05-15 11:19 am Sale | 2026-03-31 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Armistice Capital, LLC | 291,155 9.990% | -2,384,455 (-89.12%) | Filing History |
| 2026-05-13 4:28 pm Sale | 2026-03-31 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Mitchell P. Kopin | 233,337 9.990% | -4,572,837 (-95.15%) | Filing History |
| 2026-02-17 9:45 pm Unchanged | 2025-12-31 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Armistice Capital, LLC | 2,675,610 8.260% | 0 (Unchanged) | Filing History |
| 2026-02-17 08:00 am Purchase | 2025-12-31 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | L1 Capital Global Opportunities Master Fund, Ltd. | 547,715 1.790% | 488,715 (+828.33%) | Filing History |
| 2026-02-13 4:41 pm Purchase | 2025-12-31 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Mitchell P. Kopin | 4,806,174 9.990% | 4,692,200 (+4116.90%) | Filing History |
| 2026-02-11 10:05 am Purchase | 2025-12-31 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Ayrton Capital LLC | 4,810,451 9.990% | 4,810,451 (New Position) | Filing History |
| 2025-11-07 5:24 pm Purchase | 2025-09-30 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Mitchell P. Kopin | 113,974 9.990% | 2,278 (+2.04%) | Filing History |
| 2025-08-14 9:18 pm Purchase | 2025-06-30 | 13G | BELLICUM PHARMACEUTICALS INC C BLCM | Armistice Capital, LLC | 2,675,610 9.540% | 1,487,509 (+125.20%) | Filing History |
| 2025-07-08 5:02 pm Purchase | 2025-07-01 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Mitchell P. Kopin | 111,696 9.990% | 111,696 (New Position) | Filing History |
| 2025-07-07 4:30 pm Purchase | 2025-07-02 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | L1 Capital Global Opportunities Master Fund, Ltd. | 59,000 5.860% | 59,000 (New Position) | Filing History |
| 2025-05-15 3:15 pm Purchase | 2025-03-31 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Armistice Capital, LLC | 64,509 9.990% | 44,685 (+225.41%) | Filing History |
| 2025-02-14 5:35 pm Sale | 2024-12-31 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Armistice Capital, LLC | 19,824 4.990% | -18,021 (-47.62%) | Filing History |
| 2024-11-14 5:10 pm Sale | 2024-09-30 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Armistice Capital, LLC | 37,845 9.990% | -86,598 (-69.59%) | Filing History |
| 2024-02-14 3:38 pm Purchase | 2023-12-31 | 13G | GEOVAX LABS INC PAR $0.001 GOVX | Armistice Capital, LLC | 124,443 9.990% | 123,941 (+24689.44%) | Filing History |
| 2022-02-11 5:48 pm Sale | 2021-12-31 | 13G | GEOVAX LABS INC PAR $.0001 GOVX | L1 Capital Global Opportunities Master Fund, Ltd. | 0 0.000% | -1,024 (Position Closed) | Filing History |